Table 1. Characteristics of the study participants.
AD patients (N = 936) | Controls (N = 776) | p-value | ||
Age (years) | (mean±SD) | 76.5±7.6 | 73.7±7.2 | |
Gender | Female | 72.9% | 60.6% | <0.0001 |
Male | 27.1% | 39.4% | ||
APOE4 status | APOE4+ | 43.5% | 13.1% | <0.0001 |
APOE4- | 56.5% | 86.9% | ||
Female | (N = 682) | (N = 470) | ||
Age (years) | (mean±SD) | 77.1±7.7 | 73.8±7.2 | |
APOE4 status | APOE4+ | 43.4% | 11.1% | <0.0001 |
APOE4- | 56.6% | 88.9% | ||
Male | (N = 254) | (N = 306) | ||
Age (years) | (mean±SD) | 75.1±7.2 | 73.4±7.1 | |
APOE4 status | APOE4+ | 43.7% | 16.3% | <0.0001 |
APOE4- | 56.3% | 83.7% |